medigraphic.com
ISSN 2221-2434 (Electronic)

2013, Number 1

<< Back Next >>

Finlay 2013; 3 (1)

Palliative Care for Patients Suffering from Cancer in Seychelles´ Hospice

Roca SAC, Reginald L, Henriette K

Language: Spanish
References: 32
Page: 34-42
PDF size: 409.08 Kb.


ABSTRACT

Background: the high prevalence of cancer in middle and low-income countries increases daily care needs in the hospice.
Objective: to determine the behavior of some biological variables in patients in final cancer stage.
Methods: a descriptive study on 28 patients with final stage neoplasia diagnosis, admitted to the Seychelles Hospice from February 2010 to February 2011 was conducted. The behavior of cancer in relation to the following variables was analyzed: age, sex, primary location, response to Charlson index, Karnofsky and ECOG scales, presence of chronic noncommunicable diseases and health scenario responsible for the remission.
Results: 54,9 % of patients admitted to the hospice had an oncological disease, 53,57 % of them were males. The age group with the highest number of cases was that from 50 to 59 years, with an average age of 68,6 years (± 15,71). Head and neck malignancies in men and colorectal in women were the most common diagnoses. In general, average stay was 40,5 days (± 60,23). Hypertension and diabetes mellitus were the most frequent noncommunicable diseases. 75 % of the cases were submitted from hospitals.
Conclusions: final cancer stage shows a behavior that can anticipate an adequate strategy in the transition to palliative care provided by the hospice.


REFERENCES

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011 ; 61 (2): 69-2.

  2. Finlay E, Casarett D. Making difficult discussions easier:using prognosis to facilitate transitions to hospice. CA Cancer J Clin. 2009 ; 59 (4): 250-63.

  3. Ford DW, Nietert PJ, Zapka J, Zoller JS, Silvestri GA. Barriers to hospice enrollment among lung cancer patients:a survey of family members and physicians. Palliat Support Care. 2008 ; 6 (4): 357-62.

  4. Weckmann MT. The role of the family physician in the referral and management of hospice patients. Am Fam Physician. 2008 ; 77 (6): 807-12.

  5. Balfour S. Design of care:the hospice visit. Home Healthc Nurse. 2008 ; 26 (10): 633-40.

  6. Maltoni M, Nanni O, Pirovano M, Scarpi E, Indelli M, Martini C, et al. Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage. 1999 ; 17 (4): 240-7.

  7. Berkman LF, Leo Summers L, Horwitz RI. Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med. 1992 ; 117 (12): 1003-9.

  8. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH. The use of nitrogen mustards in the palliative treatment of carcinoma. With particular reference to brochogenic carcinoma. Cancer. 1948 ; 1 (4): 634-56.

  9. Oken MM, Creech RH, Tormey DC. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982 ; 5 (6): 649-55.

  10. Tang ST, Huang EW, Liu TW, Wang HM, Chen JS. A population-based study on the determinants of hospice utilization in the last year of life for Taiwanese cancer decedents, 2001-2006. Psychooncology. 2010 ; 19 (11): 1213-20.

  11. Jenkins TM, Chapman KL, Harshbarger DS, Townsend JS. Hospice use among cancer decedents in Alabama, 2002-2005. Prev Chronic Dis. 2009 ; 6 (4): A119.

  12. Younis T, Milch R, Abul-Khoudoud N, Lawrence D, Mirand A, Levine E. Length of survival in hospice for cancer patients referred from a comprehensive cancer center. Am J Hosp Palliat Care. 2009 ; 26 (4): 281-7.

  13. Ostgathe C, Alt-Epping B, Golla H, Gaertner J, Lindena G, Radbruch L, et al. Non-cancer patients in specialized palliative care in Germany:what are the problems?. Palliat Med. 2011 ; 25 (2): 148-52.

  14. Lepore MJ, Miller SC, Gozalo P. Hospice use among urban Black and White U.S. nursing home decedents in 2006. Gerontologist. 2011 ; 51 (2): 251-60.

  15. Shahmoradi N, Kandiah M, Peng LS. Impact of nutritional status on the quality of life of advanced cancer patients in hospice home care. Asian Pac J Cancer Prev. 2009 ; 10 (6): 1003-9.

  16. Fang CR, Chen HW, Liu SI, Lin CJ, Tsai LY, Lai YL. Prevalence, detection and treatment of delirium in terminal cancer inpatients:a prospective survey. Jpn J Clin Oncol. 2008 ; 38 (1): 56-63.

  17. McMillan SC, Small BJ, Haley WE. Improving hospice outcomes through systematic assessment a clinical trial. Cancer Nurs. 2011 ; 34 (2): 89-97.

  18. Population and Vital Statistics 2010. National Bureau of Statistics. (Seychelles) [revista en Internet]. 2011 [ cited 24 Jun 2011 ] ; 1: [aprox. 34p]. Available from: http://www.nbs.gov.sc/files/Population%20and%2 0Vital%20Statistics/2011/popstats_01_2011.pdf.

  19. Lang K, Lines LM, Lee WD, Korn JR, Earle CC, Menzin J. Trends in healthcare utilization among older Americans with colorectal cancer:a retrospective database anlaysis. BMC Health Serv Res. 2009 ; 9: 227.

  20. Shugarman LR, Bird CE, Schuster CR, Lynn J. Age and gender differences in medicare expenditures and service utilization at the End of life for lung cancer decedents. Womens Health Issues. 2008 ; 18 (3): 199-209.

  21. Sesterhenn AM, Folz BJ, Bieker M, Teymoortash A, Werner JA. End-of-life care for terminal head and neck cancer patients. Cancer Nurs. 2008 ; 31 (2): E40-6.

  22. Gozalo PL, Miller SC, Intrator O, Barber JP, Mor V. Hospice effect on government expenditures among nursing home residents. Health Serv Res. 2008 ; 43 (1): 134-53.

  23. Bruera E, Hui D. Integrating supportive and palliative care in the trajectory of cancer:establishing goals and models of care. J Clin Oncol. 2010 ; 28 (25): 4013-7.

  24. Miyashita M, Morita T, Hikai K. Evaluation of end-of-life cancer care from the perspective of bereaved family members:the Japanese experience. J Clin Oncol. 2008 ; 26 (23): 3845-52.

  25. Carlson MD, Herrin J, Du Q, Epstein AJ, Cherlin E, Morrinson SR, et al. Hospice characteristics and the disenrollment of patients with cancer. Health Serv Res. 2009 ; 44 (6): 2004-21.

  26. Chang PM, Liu YY, Chao TC, Lin HL, Chen MB, Chen PM, et al. A new hospice consulting system for terminal cancer patients in transferring to post-acute care options in Taiwan. Eur J Cancer Care (Engl). 2010 ; 19 (2): 267-72.

  27. Temel JS, McCannon J, Greer JA, Jackson VA, Ostler P, Pirl WF, et al. Aggressiveness of care in a prospective cohort of patients with advanced NSCLC. Cancer. 2008 ; 113 (4): 826-33.

  28. Casarett DJ, Fishman JM, Lu HL, O Dwyer PJ, Barg FK, Naylor MD, et al. The terrible choice:re-evaluating hospice eligibility criteria for cancer. J Clin Oncol. 2009 ; 27 (6): 953-9.

  29. Fishman J, O Dwyer P, Lu HL, Henderson H, Asch DA, Casarett DJ. Race, treatment preferences, and hospice enrollment:eligibility criteria may exclude patients with the greatest needs for care. Cancer. 2009 ; 115 (3): 689-97.

  30. Maltoni M, Amadori D. Prognosis in advanced cancer. Hematol Oncol Clin NorthAm. 2002 ; 16 (3): 715-29.

  31. Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A. Predicting survival in patients with advanced disease. Eur J Cancer. 2008 ; 44 (8): 1146-56.

  32. Errante D, De Chirico C, Salvagno L. Comment on older cancer patients in an Italian hospice. Ann Oncol. 2009 ; 26 (6): 1146-7.




2020     |     www.medigraphic.com